Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells

Hon Chi Lee, James J. Matsuda, Sandra I. Reynertson, James B. Martins, Erwin F. Shibata

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were per-formed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 μM) was significant at various concentrations of lidocaine (20, 65, and 100 μM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 μM) significantly suppressed epicardial impulse conduction in both longitudinal (θL, 0.430±0.024 vs. 0.585±0.001 m/s at baseline, n = 7, P < 0.001) and transverse (θT, 0.206±0.012 vs. 0.257±0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 μM) significantly reversed the lidocaine effects with θL of 0.503±0.027 m/s and θT of 0.234±0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs.

Original languageEnglish (US)
Pages (from-to)693-701
Number of pages9
JournalJournal of Clinical Investigation
Volume91
Issue number2
StatePublished - Feb 1993
Externally publishedYes

Fingerprint

Lidocaine
Isoproterenol
Sodium
Rabbits
Sodium Channels
Anti-Arrhythmia Agents
Muscle Cells
Epicardial Mapping
Patch-Clamp Techniques
GTP-Binding Proteins

Keywords

  • β-adrenergic stimulation
  • Antiarrhythmic drugs
  • Cardiac myocytes
  • Conduction velocities
  • Sodium channels

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, H. C., Matsuda, J. J., Reynertson, S. I., Martins, J. B., & Shibata, E. F. (1993). Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells. Journal of Clinical Investigation, 91(2), 693-701.

Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells. / Lee, Hon Chi; Matsuda, James J.; Reynertson, Sandra I.; Martins, James B.; Shibata, Erwin F.

In: Journal of Clinical Investigation, Vol. 91, No. 2, 02.1993, p. 693-701.

Research output: Contribution to journalArticle

Lee, HC, Matsuda, JJ, Reynertson, SI, Martins, JB & Shibata, EF 1993, 'Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells', Journal of Clinical Investigation, vol. 91, no. 2, pp. 693-701.
Lee, Hon Chi ; Matsuda, James J. ; Reynertson, Sandra I. ; Martins, James B. ; Shibata, Erwin F. / Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells. In: Journal of Clinical Investigation. 1993 ; Vol. 91, No. 2. pp. 693-701.
@article{86ab055c60444dca90228e799a4f214e,
title = "Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells",
abstract = "We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were per-formed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 μM) was significant at various concentrations of lidocaine (20, 65, and 100 μM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 μM) significantly suppressed epicardial impulse conduction in both longitudinal (θL, 0.430±0.024 vs. 0.585±0.001 m/s at baseline, n = 7, P < 0.001) and transverse (θT, 0.206±0.012 vs. 0.257±0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 μM) significantly reversed the lidocaine effects with θL of 0.503±0.027 m/s and θT of 0.234±0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs.",
keywords = "β-adrenergic stimulation, Antiarrhythmic drugs, Cardiac myocytes, Conduction velocities, Sodium channels",
author = "Lee, {Hon Chi} and Matsuda, {James J.} and Reynertson, {Sandra I.} and Martins, {James B.} and Shibata, {Erwin F.}",
year = "1993",
month = "2",
language = "English (US)",
volume = "91",
pages = "693--701",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells

AU - Lee, Hon Chi

AU - Matsuda, James J.

AU - Reynertson, Sandra I.

AU - Martins, James B.

AU - Shibata, Erwin F.

PY - 1993/2

Y1 - 1993/2

N2 - We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were per-formed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 μM) was significant at various concentrations of lidocaine (20, 65, and 100 μM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 μM) significantly suppressed epicardial impulse conduction in both longitudinal (θL, 0.430±0.024 vs. 0.585±0.001 m/s at baseline, n = 7, P < 0.001) and transverse (θT, 0.206±0.012 vs. 0.257±0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 μM) significantly reversed the lidocaine effects with θL of 0.503±0.027 m/s and θT of 0.234±0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs.

AB - We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were per-formed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 μM) was significant at various concentrations of lidocaine (20, 65, and 100 μM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 μM) significantly suppressed epicardial impulse conduction in both longitudinal (θL, 0.430±0.024 vs. 0.585±0.001 m/s at baseline, n = 7, P < 0.001) and transverse (θT, 0.206±0.012 vs. 0.257±0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 μM) significantly reversed the lidocaine effects with θL of 0.503±0.027 m/s and θT of 0.234±0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs.

KW - β-adrenergic stimulation

KW - Antiarrhythmic drugs

KW - Cardiac myocytes

KW - Conduction velocities

KW - Sodium channels

UR - http://www.scopus.com/inward/record.url?scp=0027395953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027395953&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 693

EP - 701

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -